Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study.

scientific article published on 9 September 2011

Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EURURO.2011.08.073
P932PMC publication ID3628750
P698PubMed publication ID21924544
P5875ResearchGate publication ID51648976

P50authorShahrokh ShariatQ7462263
Eugene K. ChaQ37839556
P2093author name stringArnulf Stenzl
Paul J Christos
Christian Schwentner
Joerg Hennenlotter
Armin Pycha
Bernd J Schmitz-Dräger
Thomas Martini
Lenuta-Ancuta Tirsar
Christine Mian
P2860cites workDecision curve analysis: a novel method for evaluating prediction modelsQ34581068
Comparisons of nomograms and urologists' predictions in prostate cancerQ34638482
Urine markers for bladder cancer surveillance: a systematic reviewQ36144538
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladderQ37158767
Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladderQ39211380
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errorsQ39605793
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference CommitteeQ40831782
Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-upQ46156479
Patterns of hematuria referral to urologists: does a gender disparity exist?Q51694266
Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.Q52933297
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancerQ59649685
Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter studyQ78953902
Immunocytology in the assessment of patients with asymptomatic microhaematuriaQ79362303
Immunocytology in the assessment of patients with asymptomatic hematuriaQ80187307
Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United StatesQ81170464
uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analysesQ82255240
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladderQ82853564
Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based surveyQ83038592
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmulticenter clinical trialQ6934595
bladder cancerQ504775
P304page(s)185-192
P577publication date2011-09-09
P1433published inEuropean UrologyQ15763991
P1476titleImmunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study
P478volume61

Reverse relations

cites work (P2860)
Q89184326An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
Q51297927Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
Q38177471Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer
Q38650676Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer
Q47103658Cytokeratin 20/p53 dual immunocytochemistry for improving the diagnostic accuracy of urine liquid-based cytology in the detection of urothelial neoplasm: A retrospective study
Q38511509Developing proteomic biomarkers for bladder cancer: towards clinical application
Q54449190Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer.
Q39177122Evaluation of double immunocytochemical staining for CK20 and P53 as a potential adjunct to cytology for urothelial cancer diagnosis
Q38957991Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines
Q91794064Molecular markers in bladder cancer
Q47721208The contemporary role and impact of urine-based biomarkers in bladder cancer
Q35021819The use of molecular analyses in voided urine for the assessment of patients with hematuria.
Q58705097Urinary Biomarkers in the Evaluation of Primary Hematuria: A Systematic Review and Meta-Analysis
Q38195145Urinary immunocytology--promise or nonseller? A review with an opinion
Q45139625Urine cytology - update 2013. A systematic review of recent literature
Q38140308Urine markers for detection and surveillance of bladder cancer